Print Email Facebook Twitter Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors Title Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors Author Visser, J. Lentjes, E. Haspels, I. Graffelman, W. Blauw, B. de Kloet, R. Nagelkerken, L. TNO Preventie en Gezondheid Publication year 2001 Abstract Background: In this study we tested the hypothesis that the increased sensitivity to glucocorticoids in chronic fatigue syndrome (CFS)-patients can be attributed to an altered functioning of their glucocorticoid receptors (GR). Methods: For this purpose, affinity and distribution of the GR were studied in purified, peripheral blood mononuclear cells (PBMC) of 10 CFS patients and 14 controls along with the responsiveness of these cells to glucocorticoids in vitro. Results: Affinity (Kd) and number of GR was not different in PBMC of CFS patients when compared with the controls (Kd, 12.9±8.9 nmol vs 18.8±16.2 nmol and GR number, 4839±2824/ cell vs 4906±1646/cell). Moreover, RT-PCR revealed no differences in GR messenger RNA expression. Nevertheless, PBMC from CFS patients showed an increased sensitivity to glucocorticoids in vitro. In CFS patients 0.01 μmol dexamethasone suppressed PBMC proliferation by 37%, whereas the controls were only suppressed by 17% (P<0.01). Addition of phorbol 12-myristate 13-acetate to the cultures rendered the cells resistant to dexamethasone with regard to proliferation and IL-10 and IFN-γ production, but not to IL-2 and TNF-α production in both patients and controls. No difference between patients and controls was observed in this respect. Conclusions: In conclusion, PBMC of CFS patients display an increased sensitivity to glucocorticoids, which cannot be explained by number or affinity of the GR but should rather be attributed to molecular processes beyond the actual binding of the ligand to the GR. Chemicals/CAS: Adrenocorticotropic Hormone, 9002-60-2; Cytokines; Dexamethasone, 50-02-2; Hydrocortisone, 50-23-7; Receptors, Glucocorticoid; Tetradecanoylphorbol Acetate, 16561-29-8 Subject HealthChronic fatigue syndromeGlucocorticoid receptorsGlucocorticoidsDexamethasoneGamma interferonGlucocorticoidGlucocorticoid receptorInterleukin 10Interleukin 2Iessenger RNAPhorbol 13 acetate 12 myristateTumor necrosis factor alphaClinical articlecontrolled studyCorticotropin blood levelCytokine productionEnzyme linked immunosorbent assayHormone sensitivityHuman cellHydrocortisone blood levelMononuclear cellreceptor affinityreceptor densityreverse transcription polymerase chain reactionAdolescentAdrenocorticotropic HormoneAdultCells, CulturedCytokinesDexamethasoneFatigue Syndrome, ChronicFemaleHumansHydrocortisoneLeukocytes, MononuclearMaleMiddle AgedReceptors, GlucocorticoidTetradecanoylphorbol Acetate To reference this document use: http://resolver.tudelft.nl/uuid:dc92d97a-2780-4308-8fc3-57c066edb9de TNO identifier 236002 ISSN 1081-5589 Source Journal of Investigative Medicine, 49 (2), 195-204 Document type article Files To receive the publication files, please send an e-mail request to TNO Library.